Abstract
Clinical pathology endpoints are evaluated during the course of toxicity studies to monitor structural and functional changes in organs and tissues in response to administration or withdrawal of a test item. A variety of assays can be performed in a clinical pathology laboratory with body fluids using either clinical pathology analyzers or other instruments. Information from the basic assays in clinical pathology, including hematology, clinical chemistry, urinalysis and coagulation are used with other safety assessment endpoints to evaluate immunotoxicity. Non-routine clinical pathology variables, such as acute phase proteins, cytokines, complement, hormones, autoantibodies, and bone marrow cytology are also included in preclinical toxicity studies as supplementary assays to ensure adequate interpretation of test item-related effects on the immune system. This chapter will describe the clinical pathology assays that are most useful to assess immunotoxicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adam SS, Key NS, Greenberg CS (2009) D-dimer antigen: current concepts and future prospects. Blood 113(13):2878–2887. doi:10.1182/blood-2008-06-165845
Aggarwal A (2014) Role of autoantibody testing. Best Pract Res Clin Rheumatol 28(6):907–920. doi:10.1016/j.berh.2015.04.010
Ahmed MS, Jadhav AB, Hassan A, Meng QH (2012) Acute phase reactants as novel predictors of cardiovascular disease. ISRN Inflamm 2012:953461. doi:10.5402/2012/953461
Arnold DM, Kukaswadia S, Nazi I, Esmail A, Dewar L, Smith JW, Warkentin TE, Kelton JG (2013a) A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost 11(1):169–176. doi:10.1111/jth.12052
Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG (2013b) Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev 27(3):137–145. doi:10.1016/j.tmrv.2013.05.005
Aster RH, Bougie DW (2007) Drug-induced immune thrombocytopenia. N Engl J Med 357(6):580–587. doi:10.1056/NEJMra066469
Basu S, Hodgson G, Katz M, Dunn AR (2002) Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Blood 100(3):854–861
Baum J, Ward RH, Conway DJ (2002) Natural selection on the erythrocyte surface. Mol Biol Evol 19(3):223–229
Bednar B, Cook JJ, Holahan MA, Cunningham ME, Jumes PA, Bednar RA, Hartman GD, Gould RJ (1999) Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa. Blood 94(2):587–599
Bergseth G, Ludviksen JK, Kirschfink M, Giclas PC, Nilsson B, Mollnes TE (2013) An international serum standard for application in assays to detect human complement activation products. Mol Immunol 56(3):232–239. doi:10.1016/j.molimm.2013.05.221
Bonneau RH, Sheridan JF, Feng NG, Glaser R (1991) Stress-induced suppression of herpes simplex virus (HSV)-specific cytotoxic T lymphocyte and natural killer cell activity and enhancement of acute pathogenesis following local HSV infection. Brain Behav Immun 5(2):170–192
Brennan FR, Morton LD, Spindeldreher S, Kiessling A, Allenspach R, Hey A, Muller PY, Frings W, Sims J (2010) Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies. MAbs 2(3):233–255
Caviezel LL, Raj K, Giger U (2014) Comparison of 4 direct Coombs’ test methods with polyclonal antiglobulins in anemic and nonanemic dogs for in-clinic or laboratory use. J Vet Intern Med 28(2):583–591. doi:10.1111/jvim.12292
Ceron JJ, Eckersall PD, Martynez-Subiela S (2005) Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol 34(2):85–99
Chapin RE, Creasy DM (2012) Assessment of circulating hormones in regulatory toxicity studies II. male reproductive hormones. Toxicol Pathol 40(7):1063–1078
Cheretakis C, Leung R, Sun CX, Dror Y, Glogauer M (2006) Timing of neutrophil tissue repopulation predicts restoration of innate immune protection in a murine bone marrow transplantation model. Blood 108(8):2821–2826. doi:10.1182/blood-2006-04-018184
Chowdhury F, Williams A, Johnson P (2009) Validation and comparison of two multiplex technologies, Luminex and Mesoscale discovery, for human cytokine profiling. J Immunol Methods 340(1):55–64. doi:10.1016/j.jim.2008.10.002
Christoffersson G, Vagesjo E, Vandooren J, Liden M, Massena S, Reinert RB, Brissova M, Powers AC, Opdenakker G, Phillipson M (2012) VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood 120(23):4653–4662. doi:10.1182/blood-2012-04-421040
Colonna L, Lood C, Elkon KB (2014) Beyond apoptosis in lupus. Curr Opin Rheumatol 26(5):459–466. doi:10.1097/BOR.0000000000000083
Cora MC, King D, Betz LJ, Wilson R, Travlos GS (2012) Artifactual changes in Sprague-Dawley rat hematologic parameters after storage of samples at 3 degrees C and 21 degrees C. J Am Assoc Lab Anim Sci 51(5):616–621
Corsini E, House RV (2010) Evaluating cytokines in immunotoxicity testing. Methods Mol Biol 598:283–302. doi:10.1007/978-1-60761-401-2_20
Cox G (1995) Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 154(9):4719–4725
Cray C, Zaias J, Altman NH (2009) Acute phase response in animals: a review. Comp Med 59(6):517–526
Cupps TR, Gerrard TL, Falkoff RJ, Whalen G, Fauci AS (1985) Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation. J Clin Invest 75(2):754–761. doi:10.1172/JCI111757
Eber S, Lux SE (2004) Hereditary spherocytosis--defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 41(2):118–141
Elenkov IJ (2004) Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 1024:138–146. doi:10.1196/annals.1321.010
Esmon CT, Xu J, Lupu F (2011) Innate immunity and coagulation. J Thromb Haemost 9(Suppl 1):182–188. doi:10.1111/j.1538-7836.2011.04323.x
Evans GO (2009) Animal clinical chemistry: a practical handbook for toxicologists and biomedical researchers, 2nd edn. CRC Press/Taylor & Francis, Boca Raton, FL
Everds NE, Snyder PW, Bailey KL, Bolon B, Creasy DM, Foley GL, Rosol TJ, Sellers T (2013) Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol Pathol 41(4):560–614. doi:10.1177/0192623312466452
FDA (2002) Guidance for industry: immunotoxicology evaluation of investigational new drugs. Washington, DC
Fonseca AM, Pereira CF, Porto G, Arosa FA (2003) Red blood cells promote survival and cell cycle progression of human peripheral blood T cells independently of CD58/LFA-3 and heme compounds. Cell Immunol 224(1):17–28
Food and Drug Administration HHS (2006) International conference on harmonisation; guidance on S8 immunotoxicity studies for human pharmaceuticals; availability notice. Fed Regist 71(71):19193–19194
Freedman J (1987) The significance of complement on the red cell surface. Transfus Med Rev 1(1):58–70
Fry MM, Barnhart KB, Stacy N (2014) Comparative hematology, 13 edn. Lippincott Williams and Wilkins, Philadelphia, PA
Fuchs TC, Hewitt P (2011) Preclinical perspective of urinary biomarkers for the detection of nephrotoxicity: what we know and what we need to know. Biomark Med 5(6):763–779. doi:10.2217/bmm.11.86
Gad SC, McCord MG, Gad SC (2008) Safety evaluation in the development of medical devices and combination products, 3rd edn. Informa Healthcare, New York
Garratty G (2009) Drug-induced immune hemolytic anemia. Hematology/the Education Program of the American Society of Hematology American Society of Hematology Education Program. 73–79. doi:10.1182/asheducation-2009.1.73
Garratty G (2010) Immune hemolytic anemia associated with drug therapy. Blood Rev 24(4–5):143–150. doi:10.1016/j.blre.2010.06.004
Garratty G (2012) Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf 11(4):635–642. doi:10.1517/14740338.2012.678832
Garratty G, Arndt PA (2007) An update on drug-induced immune hemolytic anemia. Immunohematology 23(3):105–119
Garratty G, Arndt PA (2014) Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007. Immunohematology 30(2):66–79
Gruver-Yates AL, Quinn MA, Cidlowski JA (2014) Analysis of glucocorticoid receptors and their apoptotic response to dexamethasone in male murine B cells during development. Endocrinology 155(2):463–474. doi:10.1210/en.2013-1473
Gruys E, Toussaint MJ, Niewold TA, Koopmans SJ (2005a) Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 6(11):1045–1056. doi:10.1631/jzus.2005.B1045
Gruys E, Toussaint MJ, Upragarin N, Van EA, Adewuyi AA, Candiani D, Nguyen TK, Sabeckiene J (2005b) Acute phase reactants, challenge in the near future of animal production and veterinary medicine. J Zhejiang Univ Sci B 6(10):941–947. doi:10.1631/jzus.2005.B0941
Gupta S, Ahern K, Nakhl F, Forte F (2011) Clinical usefulness of haptoglobin levels to evaluate hemolysis in recently transfused patients. Adv Hematol 2011:389854. doi:10.1155/2011/389854
Hall RL (1992) Clinical pathology for preclinical safety assessment: current global guidelines. Toxicol Pathol 20(3 Pt 2):472–476
Harboe M, Thorgersen EB, Mollnes TE (2011) Advances in assay of complement function and activation. Adv Drug Deliv Rev 63(12):976–987. doi:10.1016/j.addr.2011.05.010
Haschek WM, Wallig MA, Rousseaux C (2010) Hematopoietic system. In: Fundamentals of toxicologic pathology, Second edn. Academic Press, San Diego, CA, pp 491–512
Heikal NM, Smock KJ (2013) Laboratory testing for platelet antibodies. Am J Hematol 88(9):818–821. doi:10.1002/ajh.23503
Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM (1999) Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 5(1):83–89. doi:10.1038/4772
Herzyk DJ, Bussiere JL (2008) Immunotoxicology strategies for pharmaceutical safety assessment. Wiley, Hoboken, N.J.
Heyen JR, Rojko J, Evans M, Brown TP, Bobrowski WF, Vitsky A, Dalton S, Tripathi N, Bollini SS, Johnson T, Lin JC, Khan N, Han B (2014) Characterization, biomarkers, and reversibility of a monoclonal antibody-induced immune complex disease in Cynomolgus monkeys (Macaca fascicularis). Toxicol Pathol 42(4):765–773. doi:10.1177/0192623314522559
Honjo T, Kuribayashi T, Matsumoto M, Yamazaki S, Yamamoto S (2010) Kinetics of {alpha}2-macroglobulin and {alpha}1-acid glycoprotein in rats subjected to repeated acute inflammatory stimulation. Lab Anim 44(2):150–154. doi:10.1258/la.2009.009042
Hurst NP, Nuki G (1981) Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. Br Med J (Clin Res Ed) 282(6282):2081–2083
International Conference on Harmonization (ICH) (1997) S6 preclinical safety evaluation of biotechnology-derived pharmaceuticals. Guidance for Industry. Federal Register, 62(222): 61515–61519
Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, van Rooijen N, MacDonald AS, Allen JE (2011) Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332(6035):1284–1288. doi:10.1126/science.1204351
Kabanova S, Kleinbongard P, Volkmer J, Andree B, Kelm M, Jax TW (2009) Gene expression analysis of human red blood cells. Int J Med Sci 6(4):156–159
Kawabata TT, Evans EW (2012) Development of immunotoxicity testing strategies for immunomodulatory drugs. Toxicol Pathol 40(2):288–293
Kenney B, Stack G (2009) Drug-induced thrombocytopenia. Arch Pathol Lab Med 133(2):309–314. doi:10.1043/1543-2165-133.2.309
Kilicarslan A, Uysal A, Roach E (2013) Acute phase reactants. Acta Medica 2:2–7
Kirschfink M, Mollnes TE (2003) Modern complement analysis. Clin Diagn Lab Immunol 10(6):982–989
Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, Black S, Galindo C, Schmidt J, Baxter R (2010) Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine 28(4):1062–1068. doi:10.1016/j.vaccine.2009.10.115
Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13(3):159–175. doi:10.1038/nri3399
Kotimaa JP, van Werkhoven MB, O′Flynn J, Klar-Mohamad N, van Groningen J, Schilders G, Rutjes H, Daha MR, Seelen MA, van Kooten C (2015) Functional assessment of mouse complement pathway activities and quantification of C3b/C3c/iC3b in an experimental model of mouse renal ischaemia/reperfusion injury. J Immunol Methods 419:25–34. doi:10.1016/j.jim.2015.02.010
Kumar Y, Bhatia A, Minz RW (2009) Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol 4:1. doi:10.1186/1746-1596-4-1
Kurts C, Panzer U, Anders HJ, Rees AJ (2013) The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol 13(10):738–753. doi:10.1038/nri3523
Kuter DJ (1997) Thrombopoiesis and thrombopoietins: molecular, cellular, preclinical, and clincial biology. Humana Press, Totowa, N.J.
Lachmann PJ (2010) Preparing serum for functional complement assays. J Immunol Methods 352(1–2):195–197. doi:10.1016/j.jim.2009.11.003
Leavy O (2011) Immunotherapy: stopping monocytes in their tracks. Nat Rev Immunol 11(11):715. doi:10.1038/nri3096
Lebrec H, O′Lone R, Freebern W, Komocsar W, Moore P (2012) Survey: immune function and immunotoxicity assessment in dogs. J Immunotoxicol 9(1):1–14. doi:10.3109/1547691x.2011.592163
Lee J, Rosenberg HF (2013) Eosinophils in health and disease, 1st edn. Elsevier/Academic Press, London/Waltham, MA
Leuschner F, Dutta P, Gorbatov R, Novobrantseva TI, Donahoe JS, Courties G, Lee KM, Kim JI, Markmann JF, Marinelli B, Panizzi P, Lee WW, Iwamoto Y, Milstein S, Epstein-Barash H, Cantley W, Wong J, Cortez-Retamozo V, Newton A, Love K, Libby P, Pittet MJ, Swirski FK, Koteliansky V, Langer R, Weissleder R, Anderson DG, Nahrendorf M (2011) Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 29(11):1005–1010. doi:10.1038/nbt.1989
Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, Chen P, Ni H (2012) Crosstalk between platelets and the immune system: Old systems with new discoveries. Adv Hematol 2012:384685. doi:10.1155/2012/384685
Lilliehook I, Tvedten HW (2011) Errors in basophil enumeration with 3 veterinary hematology systems and observations on occurrence of basophils in dogs. Vet Clin Pathol 40(4):450–458. doi:10.1111/j.1939-165X.2011.00353.x
Loeffler M, Pantel K, Wulff H, Wichmann HE (1989) A mathematical model of erythropoiesis in mice and rats. Part 1: structure of the model. Cell Tissue Kinet 22(1):13–30
Macallan DC, Wallace DL, Zhang Y, Ghattas H, Asquith B, de Lara C, Worth A, Panayiotakopoulos G, Griffin GE, Tough DF, Beverley PC (2005) B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 105(9):3633–3640. doi:10.1182/blood-2004-09-3740
Mastellos D, Prechl J, Laszlo G, Papp K, Olah E, Argyropoulos E, Franchini S, Tudoran R, Markiewski M, Lambris JD, Erdei A (2004) Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Mol Immunol 40(16):1213–1221
Mayer B, Bartolmas T, Yurek S, Salama A (2015) Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre. Transfus Med Hemother 42(5):333–339. doi:10.1159/000440673
McGrath JP (1993) Assessment of hemolytic and hemorrhagic anemias in preclinical safety assessment studies. Toxicol Pathol 21(2):158–163
Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part I–molecular mechanisms of activation and regulation. Front Immunol 6:262. doi:10.3389/fimmu.2015.00262
Min B, Brown MA, Legros G (2012) Understanding the roles of basophils: breaking dawn. Immunology 135(3):192–197. doi:10.1111/j.1365-2567.2011.03530.x
Mire-Sluis AR, Barrett YC, Devanarayan V, Koren E, Liu H, Maia M, Parish T, Scott G, Shankar G, Shores E, Swanson SJ, Taniguchi G, Wierda D, Zuckerman LA (2004) Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J Immunol Methods 289(1–2):1–16. doi:10.1016/j.jim.2004.06.002
Mollnes TE, Garred P, Bergseth G (1988) Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation. Clin Exp Immunol 73(3):484–488
Mollnes TE, Hogasen K, De Carolis C, Vaquero E, Nielsen EW, Fontana L, Perricone R (1998) High-dose intravenous immunoglobulin treatment activates complement in vivo. Scand J Immunol 48(3):312–317
Morera D, MacKenzie SA (2011) Is there a direct role for erythrocytes in the immune response? Vet Res 42:89. doi:10.1186/1297-9716-42-89
Moreschi C (1908) Neue Tatsachen uber die Blutkorperchen-agglutination. Zentralbl Bakteriol Parasitenkd Infektkr 1 Originale 46:49–51
Murphy J, Summer R, Wilson AA, Kotton DN, Fine A (2008) The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol 38(4):380–385. doi:10.1165/rcmb.2007-0224RC
Nakamura S, Shimokama T, Yoshikawa Y, Watanabe T (1990) Immune complex-induced disseminated intravascular coagulation (DIC). An experimental study. Acta Pathol Jpn 40(7):476–485
Noris M, Remuzzi G (2013) Overview of complement activation and regulation. Semin Nephrol 33(6):479–492. doi:10.1016/j.semnephrol.2013.08.001
Ohnmacht C, Voehringer D (2009) Basophil effector function and homeostasis during helminth infection. Blood 113(12):2816–2825. doi:10.1182/blood-2008-05-154773
Oppermann M, Wurzner R (2010) Modern determination of complement activation. Semin Thromb Hemost 36(6):611–619. doi:10.1055/s-0030-1262882
Park YM, Bochner BS (2010) Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol Res 2(2):87–101. doi:10.4168/aair.2010.2.2.87
Petersen BH, Heim MC, White JF (1988) Experimental drug-induced immune thrombocytopenia in monkeys. Diagn Clin Immunol 5(6):349–354
Petersen HH, Nielsen JP, Heegaard PM (2004) Application of acute phase protein measurements in veterinary clinical chemistry. Vet Res 35(2):163–187. doi:10.1051/vetres:2004002
Petz LD (2004) Review: evaluation of patients with immune hemolysis. Immunohematology 20(3):167–176
Pfeifer PH, Kawahara MS, Hugli TE (1999) Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation. Clin Chem 45(8 Pt 1):1190–1199
Pierce A, Nester T (2011) Pathology consultation on drug-induced hemolytic anemia. Am J Clin Pathol 136(1):7–12. doi:10.1309/ajcpbvljzh6w6rqm
Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, Borghans JA, Tesselaar K, Koenderman L (2010) In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 116(4):625–627. doi:10.1182/blood-2010-01-259028
Pisetsky DS (2016) Anti-DNA antibodies–quintessential biomarkers of SLE. Nat Rev Rheumatol 12(2):102–110. doi:10.1038/nrrheum.2015.151
Porto B, Fonseca AM, Godinho I, Arosa FA, Porto G (2001) Human red blood cells have an enhancing effect on the relative expansion of CD8+ T lymphocytes in vitro. Cell Prolif 34(6):359–367
Pruett SB, Collier S, Wu WJ, Fan R (1999) Quantitative relationships between the suppression of selected immunological parameters and the area under the corticosterone concentration vs. time curve in B6C3F1 mice subjected to exogenous corticosterone or to restraint stress. Toxicol Sci 49(2):272–280
Pruett SB, Fan R, Zheng Q, Myers LP, Hebert P (2000) Modeling and predicting selected immunological effects of a chemical stressor (3,4-dichloropropionanilide) using the area under the corticosterone concentration versus time curve. Toxicol Sci 58(1):77–87
Reagan JW, Irizarry-Rovira A, Poitout-Belissent F, AP B, SK R, Travlos G, Walker D, Bounous D, Walter G, Bone Marrow Working Group of AS (2011) Best practices for evaluation of bone marrow in nonclinical toxicity studies. Toxicol Pathol 39(2):435–448. doi:10.1177/0192623310396907
Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N (2001) Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 47(3):418–425
Roess DA, Bellone CJ, Ruh MF, Nadel EM, Ruh TS (1982) The effect of glucocorticoids on mitogen-stimulated B-lymphocytes: thymidine incorporation and antibody secretion. Endocrinology 110(1):169–175. doi:10.1210/endo-110-1-169
Saffar AS, Ashdown H, Gounni AS (2011) The molecular mechanisms of glucocorticoids-mediated neutrophil survival. Curr Drug Targets 12(4):556–562
Sahota PS (2013) Toxicologic pathology: nonclinical safety assessment. CRC Press, Boca Raton
Sathe PM, Patwa UD (2014) D Dimer in acute care. Int J Crit Illn Inj Sci 4(3):229–232. doi:10.4103/2229-5151.141435
Saverymuttu SH, Peters AM, Keshavarzian A, Reavy HJ, Lavender JP (1985) The kinetics of 111indium distribution following injection of 111indium labelled autologous granulocytes in man. Br J Haematol 61(4):675–685
Scott MA, Kaiser L, Davis JM, Schwartz KA (2002) Development of a sensitive immunoradiometric assay for detection of platelet surface-associated immunoglobulins in thrombocytopenic dogs. Am J Vet Res 63(1):124–129
Shen L, Frazer-Abel A, Reynolds PR, Giclas PC, Chappell A, Pangburn MK, Younis H, Henry SP (2014) Mechanistic understanding for the greater sensitivity of monkeys to antisense oligonucleotide-mediated complement activation compared with humans. J Pharmacol Exp Ther 351(3):709–717. doi:10.1124/jpet.114.219378
Smith CA, Andrews CM, Collard JK, Hall DE, Walker AK (1994) Color atlas of comparative diagnositic and experimental hematology, first edn. Wolfe, London, England
Stanislaus D, Andersson H, Chapin R, Creasy D, Ferguson D, Gilbert M, Rosol TJ, Boyce RW, Wood CE (2012) Society of toxicologic pathology position paper: review series: assessment of circulating hormones in nonclinical toxicity studies: general concepts and considerations. Toxicol Pathol 40(6):943–950
Stockham SL, Scott MA (2008) Fundamentals of veterinary clinical pathology, 2nd edn. Blackwell Pub., Ames, Iowa
Suratt BT, Young SK, Lieber J, Nick JA, Henson PM, Worthen GS (2001) Neutrophil maturation and activation determine anatomic site of clearance from circulation. Am J Physiol Lung Cell Mol Physiol 281(4):L913–L921
Szebeni J (2014) Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. Mol Immunol 61(2):163–173. doi:10.1016/j.molimm.2014.06.038
Tak T, Tesselaar K, Pillay J, Borghans JA, Koenderman L (2013) What’s your age again? Determination of human neutrophil half-lives revisited. J Leukoc Biol 94(4):595–601. doi:10.1189/jlb.1112571
Tarrant JM (2010) Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use. Toxicol Sci 117(1):4–16. doi:10.1093/toxsci/kfq134
Taub DD (2008) Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Horm 77:325–346. doi:10.1016/S0083-6729(06)77014-5
Tawara T, Hasegawa K, Sugiura Y, Harada K, Miura T, Hayashi S, Tahara T, Ishikawa M, Yoshida H, Kubo K, Ishida I, Kataoka S (2008) Complement activation plays a key role in antibody-induced infusion toxicity in monkeys and rats. J Immunol 180(4):2294–2298
Tomlinson L, Boone LI, Ramaiah L, Penraat KA, von Beust BR, Ameri M, Poitout-Belissent FM, Weingand K, Workman HC, Aulbach AD, Meyer DJ, Brown DE, MacNeill AL, Bolliger AP, Bounous DI (2013) Best practices for veterinary toxicologic clinical pathology, with emphasis on the pharmaceutical and biotechnology industries. Vet Clin Pathol 42(3):252–269. doi:10.1111/vcp.12059
Tripodi A (2011) D-dimer testing in laboratory practice. Clin Chem 57(9):1256–1262. doi:10.1373/clinchem.2011.166249
Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F (2004) Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21(2):215–226. doi:10.1016/j.immuni.2004.07.006
Tvarijonaviciute A, Martinez-Subiela S, Caldin M, Tecles F, Ceron JJ (2013) Evaluation of automated assays for immunoglobulin G, M, and A measurements in dog and cat serum. Vet Clin Pathol 42(3):270–280. doi:10.1111/vcp.12069
Verdier F, Patriarca C, Descotes J (1997) Autoantibodies in conventional toxicity testing. Toxicology 119(1):51–58
Wang J, Whetsell M, Klein JR (1997) Local hormone networks and intestinal T cell homeostasis. Science 275(5308):1937–1939
Wardrop KJ (2005) The Coombs’ test in veterinary medicine: past, present, future. Vet Clin Pathol 34(4):325–334
Webster Marketon JI, Glaser R (2008) Stress hormones and immune function. Cell Immunol 252(1–2):16–26. doi:10.1016/j.cellimm.2007.09.006
Weingand K, Brown G, Hall R, Davies D, Gossett K, Neptun D, Waner T, Matsuzawa T, Salemink P, Froelke W, Provost JP, Dal Negro G, Batchelor J, Nomura M, Groetsch H, Boink A, Kimball J, Woodman D, York M, Fabianson-Johnson E, Lupart M, Melloni E (1996) Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint scientific committee for International Harmonization of Clinical Pathology Testing. Fundam Appl Toxicol 29(2):198–201
Witkowski M, Landmesser U, Rauch U (2016) Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med 26(4):297–303. doi:10.1016/j.tcm.2015.12.001
Yamagata S, Tomita K, Sano H, Itoh Y, Fukai Y, Okimoto N, Watatani N, Inbe S, Miyajima H, Tsukamoto K, Santoh H, Ichihashi H, Sano A, Sato R, Tohda Y (2012) Non-genomic inhibitory effect of glucocorticoids on activated peripheral blood basophils through suppression of lipid raft formation. Clin Exp Immunol 170(1):86–93. doi:10.1111/j.1365-2249.2012.04636.x
Yang J, Zhang L, Yu C, Yang XF, Wang H (2014) Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res 2(1):1. doi:10.1186/2050-7771-2-1
Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A, Hume DA, Perlman H, Malissen B, Zelzer E, Jung S (2013) Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38(1):79–91. doi:10.1016/j.immuni.2012.12.001
Yoshimura C, Miyamasu M, Nagase H, Iikura M, Yamaguchi M, Kawanami O, Morita Y, Iwata T, Yamamoto K, Hirai K (2001) Glucocorticoids induce basophil apoptosis. J Allergy Clin Immunol 108(2):215–220. doi:10.1067/mai.2001.116575
Zantek ND, Koepsell SA, Tharp DR Jr, Cohn CS (2012) The direct antiglobulin test: a critical step in the evaluation of hemolysis. Am J Hematol 87(7):707–709. doi:10.1002/ajh.23218
Zhao E, Xu H, Wang L, Kryczek I, Wu K, Hu Y, Wang G, Zou W (2012) Bone marrow and the control of immunity. Cell Mol Immunol 9(1):11–19. doi:10.1038/cmi.2011.47
Ziegler-Heitbrock HW (2000) Definition of human blood monocytes. J Leukoc Biol 67(5):603–606
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Figueiredo, J.F., Barnhart, K.F., Tripathi, N. (2017). Clinical Pathology Assays in Immunopathology. In: Parker, G. (eds) Immunopathology in Toxicology and Drug Development. Molecular and Integrative Toxicology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-47377-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-47377-2_9
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-47375-8
Online ISBN: 978-3-319-47377-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)